Cargando…
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals
Most advanced prostate cancer (PCa) patients initially respond well to androgen deprivation therapy, but almost all eventually develop castration-resistant prostate cancer (CRPC). Early studies indicated the bipolar androgen therapy via a cycling of high dose and low dose of androgen to suppress PCa...
Autores principales: | Tang, Min, Sun, Yin, Huang, Chi-Ping, Chen, Lei, Liu, Bianjiang, You, Bosen, Wang, Zengjun, Chang, Chawnshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424293/ https://www.ncbi.nlm.nih.gov/pubmed/36038573 http://dx.doi.org/10.1038/s41419-022-04956-w |
Ejemplares similares
-
CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
por: Liang, Cuiwei, et al.
Publicado: (2022) -
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis
por: Guo, Changcheng, et al.
Publicado: (2022) -
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals
por: Deng, Gang, et al.
Publicado: (2021) -
Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status
por: Chen, Yuan, et al.
Publicado: (2015) -
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling
por: Liu, Qing, et al.
Publicado: (2022)